Salmonella enterica serotype typhimurium expressing L-methioninase SGN1
Term · Oncology and biomedicine · MLC-T-ONC-016624
A genetically modified strain of Salmonella enterica, serotype typhimurium that expresses L-methioninase, with potential antineoplastic activity. Upon administration, Salmonella enterica serotype typhimurium expressing L-methioninase SGN1 selectively accumulates and replicates in tumor cells, inhibiting the growth of tumors. SGN1 also delivers the oncolytic enzyme L-methioninase, a pyridoxal phosphate-dependent enzyme that catalyzes the elimination of L-methionine, to tumor cells. This eliminates L-methionine and results in cell-cycle arrest at the S/G2 phase and tumor cell death. Most tumors are methionine-dependent for growth and proliferation.
| Identifier | MLC-T-ONC-016624 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016624",
"term": "Salmonella enterica serotype typhimurium expressing L-methioninase SGN1",
"field": "Oncology and biomedicine",
"definition": "A genetically modified strain of Salmonella enterica, serotype typhimurium that expresses L-methioninase, with potential antineoplastic activity. Upon administration, Salmonella enterica serotype typhimurium expressing L-methioninase SGN1 selectively accumulates and replicates in tumor cells, inhibiting the growth of tumors. SGN1 also delivers the oncolytic enzyme L-methioninase, a pyridoxal phosphate-dependent enzyme that catalyzes the elimination of L-methionine, to tumor cells. This eliminates L-methionine and results in cell-cycle arrest at the S/G2 phase and tumor cell death. Most tumors are methionine-dependent for growth and proliferation.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/salmonella-enterica-serotype-typhimurium-expressing-l-methioninase-sgn1/"
}
Record 14,654 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.